As Consultant continues to evolve to meet the needs of today’s time-constrained clinicians, we remain committed to publishing concise, clinically actionable content, and we invite you to contribute.
On May 22, 2026, the FDA approved datopotamab deruxtecan-dlnk for adults with unresectable or metastatic triple-negative breast cancer who are not candidates for PD-1/PD-L1 inhibitor therapy, based on...
As Consultant continues to evolve to meet the needs of today’s time-constrained clinicians, we remain committed to publishing concise, clinically actionable content, and we invite you to contribute.
In the latest installment of the Myelofibrosis Caregiver Interview Series, Tim F. from Pittsburgh, PA, talks with Fadi Haddad, MD about the caregiver perspective, highlighting the substantial day-to-day...
In this video, Kevin Bozic, MD, MBA, the Chair of the Department of Surgery and Perioperative Care at Dell Medical School at the University of Texas, Austin discusses why meaningful progress in value-based...
In this video recap, Annie Truss, MD, outlines practical strategies to evaluate high-impact disease, identifies underrecognized presentations in skin of color, and incorporates newer therapies into routine...
Rachel Blansfield, BS; Nicholas Jennelly, MD; Thomas N. Helm, MD
A 54-year-old woman with a history of mitral valve replacement and warfarin therapy presented to the emergency department with worsening right lower extremity pain.
A previously healthy 73-year-old man was brought to Temple University Hospital in Philadelphia, PA by family members after experiencing anorexia and persistently elevated fevers for 4 to 5 days.
